较高的HbA1c与白质超强度在2年内更大的进展有关
Noah Schweitzer1, Sang Joon Son2, Howard Aizenstein1,3
1Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA.
Diabetes
|January 11, 2024
概括
较高的HbA1c水平与两年内白质超强度 (WMH) 进展的增加相关,特别是在非APOE ε4载体和糖尿病患者中. 这表明糖尿病可能会恶化脑血管疾病.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 放射学 放射学是一门学科.
背景情况:
- 在MRI上白质过强度 (WMH) 表明大脑小血管疾病.
- 以前对糖尿病和WMH进展的研究显示了不一致的结果.
研究的目的:
- 为了研究HbA1c和纵向WMH变化之间的关联.
- 为了在分析中调整已知的风险因素.
主要方法:
- 从韩国记忆诊所招募了64名参与者.
- 在基线和2年随访时进行脑部MRI.
- 分析了HbA1c和WMH体积变化之间的关联.
主要成果:
- 较高的HbA1c与更大的全球WMH体积变化相关 (β = 7.7 × 10-4; P = 0.025).
- 只有在糖尿病水平 (>6.51%) 时,WMH进展与HbA1c有关.
- 非APOE ε4载体显示出HbA1c和WMH进展之间更强的关联 (β = -2.59 × 10-3;P = 0.004).
- 关联在深白质和额叶/叶中更为明显.
结论:
- 升高的HbA1c水平与两年内WMH进展的增加有关.
- 这种影响在非APOE ε4载体和具有糖尿病HbA1c水平的人群中更为显著.
- 研究结果表明,糖尿病可能会加剧脑血管和白质疾病.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


